Welcome to LookChem.com Sign In|Join Free

Xi`an Eastling Biotech Co., Ltd.

Diamond Supplier

Diamond
Supplier
1st
years
Home>>Products>>Eastling Sell Top quality Kanamycin Sulphate

Product Certification&
Enterprise Certification

More Detail

Xi`an Eastling Biotech Co., Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.Spike

Tel: +86-156-91766041

Mobile:

Tel: +86-156-91766041

Fax:

URL: http://www.eastlingbiotech.com/

Province/state: Shaanxi

City: Xi'an city

Street: No. 201, Unit 4, Building 9, Hongqi Community, Tanjia Street, Weiyang District, Xi 'an, Shaanxi

MaxCard:


Contact Suppliers

Eastling Sell Top quality Kanamycin Sulphate

CAS NO.25389-94-0

  • FOB Price: USD: 23.00-25.00 /Kilogram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: T/T,Other
  • Available Specifications:

    99%(1-25)Kilogram99%(26-100)Metric Ton99%(101-500)Kilogram

Contact Supplier

Product Details

Keywords

  • Kanamycin Sulphate
  • 25389-94-0
  • Kanamytrex

Quick Details

  • ProName: Eastling Sell Top quality Kanamycin Su...
  • CasNo: 25389-94-0
  • Molecular Formula: C18H38N4O15S
  • Appearance: White crystalline powder
  • Application: Food,Cosmetics,Pharmaceutical,health p...
  • DeliveryTime: 7-10 days
  • PackAge: 1kg/bag,5kg/bag,25kg/drum
  • Port: Beijing,Shanghai
  • ProductionCapacity: 2000 Kilogram/Month
  • Purity: 99%
  • Storage: in a cool&dry place
  • Transportation: FEDEX,DHL,UPS,AIR,SEA
  • LimitNum: 1 Kilogram
  • Related Substances: <2%
  • Residue on Ignition: <0.1%
  • Heavy Metal: <10ppm
  • Valid Period: 2 years
  • Mesh: 30 Mesh

Superiority

kanamycin sulfate mixture of components A

CAS: 70560-51-9;25389-94-0;133-92-6

Molecular Formula: C18H38N4O15S

  1. Home
  2. Product Category
  3. Biomedicine
  4. Veterinary medicine
  5. 25389-94-0

25389-94-0 - Names and Identifiers

Name kanamycin sulfate mixture of components A
Synonyms Kanamycin Sulfate
Kanamycin Monosulfate
KANAMYCIN MONOSULFATE
Kanamycin Sulfate Usp
Kanamycin Sulfate Salt
KANAMYCIN MONO SULPHATE
Kanamycin Mono Sulphate
Kanamycin Sulfate White
C18H36-37N4-5O10-11H2SO4
KANAMYCIN MONOSULFATE SALT
Kanamycin Monosulfate Salt
Kanmycin MonosulfateSulfate
Kanamycin Solution Hybri-Max
kanamycin sulfate mixture of components A
KANAMYCIN SULFATE MIXTURE OF COMPONENTS A,B AND C
2-(Aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol sulfate
(1S,2R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside sulfate (salt)
(1R,2S,3S,4R,6R)-4,6-Diamino-3-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 6-amino-6-deoxy-α-L-galactopyranoside sulfate (salt)
(2S,3S,4R,5S,6S)-2-(aminomethyl)-6-[(1R,2S,3S,4R,6R)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol,sulfuric acid
CAS 70560-51-9
25389-94-0
133-92-6
EINECS 684-844-0
InChI InChI=1/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5-,6+,7-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18+;/m1./s1

25389-94-0 - Physico-chemical Properties

Molecular Formula C18H38N4O15S
Molar Mass 582.58
Melting Point 250℃
Boling Point 943.2°C at 760 mmHg
Specific Rotation(α) 117.5 ° (C=1, H2O)
Flash Point 524.2°C
Solubility It is soluble in water and almost insoluble in chloroform or ether.
Vapor Presure 0mmHg at 25°C
Appearance grayish white powder
Color white to off-white
BRN 3874279
Storage Condition 2-8°C
MDL MFCD00070253
Physical and Chemical Properties

Melting Point:> 250
solubility: H2O: 10-50 mg/mL As a stock solution. Stock solutions should be stored at 2-8 ℃. Stable at 37 °c for 5 days.
storage conditions: 2-8 ℃
WGK Germany:3
RTECS:NZ3225030

Use For the treatment of esophagitis, antral gastritis, bacillary dysentery and digestive tract infections

25389-94-0 - Risk and Safety

Risk Codes 61 - May cause harm to the unborn child
Safety Description S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S53 - Avoid exposure - obtain special instructions before use.
S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
WGK Germany 3
RTECS NZ3225030

25389-94-0 - Upstream Downstream Industry

Raw Materials Zinc sulphate
Ferrous sulfate
Ammonium chloride
Sodium nitrate
Ethyl Alcohol

25389-94-0 - Reference

Reference 

Show more

1. Wei Qinglan, Zhang Jipei, Ren Tao, et al. Drug Sensitivity Analysis of Escherichia coli from waterfowl in Guangdong p...

25389-94-0 - Reference Information

Use for the treatment of esophagitis, antral gastritis, bacillary dysentery and gastrointestinal infections

Last Update:2023-12-21 00:21:33

25389-94-0 - Nature

Storage Conditions 2-8°C
Solubility H2O: 10-50 mg/mL As a stock solution. Stock solutions should be stored at 2-8°C. Stable at 37°C for 5 days.
form powder

Last Update:2024-01-02 23:10:35

25389-94-0 - Safety Information

Mark Xi,T
Hazard code 61
WGK Germany 3
Rpecs# NZ3225030

Last Update:2024-01-02 23:10:35

25389-94-0 - Role and use

This product is aminoglycoside broad-spectrum antibiotics, antibacterial spectrum and neomycin similar. The main Gram-negative bacteria such as Escherichia coli, Klebsiella, Proteus, Pneumonia Bacillus, Enterobacter aerogenes and Shigella caused by serious infection, the drug resistance of Staphylococcus aureus also has a good antibacterial effect. Clinically, it is mainly used for pulmonary infection, urinary tract infection, biliary tract infection, sepsis and abdominal infection caused by sensitive bacteria, and the latter two are often used in combination with other antibacterial drugs. Can also be used for other antibiotic resistance and sensitive to this product of Staphylococcus aureus infection. For the treatment of tuberculosis, this product can be used as a second-line drug.

principle

  1. This product mainly binds to the 30S subunit of bacterial ribosomes and inhibits bacterial protein synthesis. In recent years, the number of resistant strains has increased significantly, because some bacteria produce aminoglycoside inactivation enzymes, so that the loss of antibacterial activity. Kanamycin and streptomycin, neomycin have complete cross-resistance, and other aminoglycosides may have some cross-resistance.
  2. This product mainly binds to the 30S subunit of bacterial ribosomes and inhibits bacterial protein synthesis.

Last Update:2024-01-02 23:10:35

25389-94-0 - Dosage and usage

  1. adult dosage: intramuscular injection or intravenous infusion, once 0.5g, once every 12 hours; Or according to body weight once 7.5mg/kg, once every 12 hours, adult daily dosage should not exceed 1.5g, treatment is not easy to exceed 14 days. Patients over 50 years of age should be appropriately reduced.
  2. Children's usual dosage: intramuscular injection or intravenous drip, according to the weight of 15-25mg/kg a day, divided into two doses.
  3. dosage when renal function decreases: creatinine clearance 50-90mg/min with 60-90% of the normal dose, once every 12 hours (normal dose is 7.5mg/kg each time, once every 12 hours); Creatinine clearance 10-50mg/min with 30-70% of the normal dose, once every 12-18 hours; Creatinine clearance <10mg/min with 20-30% of the normal dose, every 24-48 hours.

Last Update:2024-01-02 23:10:35

25389-94-0 - Adverse reactions

  1. This product is toxic, and the main toxicity is the toxicity of the eighth pair of cranial nerves.
  2. Renal toxicity, often can cause mild proteinuria, tubular urine and urine in a small number of red blood cells, white blood cells, occasionally can cause blood urea nitrogen increased.
  3. neurotoxic manifestations are muscular nerve block, which can cause respiratory paralysis, sensory numbness, visual abnormalities, etc.
  4. allergic reactions, there may be maculopapular rash, drug fever, skin itching, eosinophilia and so on.
  5. Compatibility with alkaline drugs may increase toxicity. The antibacterial activity of this product in the urinary system can be enhanced with the same use of alkalinizing urine drugs, but the toxicity is also increased, so the dose must be reduced accordingly.
  6. the general course of treatment should not exceed 2 weeks, and should be used with caution in patients with renal dysfunction. The dose should be reduced in elderly patients.

Details

Kanamycin sulfate

Mol Download Chemical properties

CAS:

25389-94-0

MF:

C18H38N4O15S

MW:

582.58

EINECS:

246-933-9

MDL No.:

MFCD00070253

Properties

Melting point:

250°C

alpha 

+112~+123°(D/20℃)(c=1,H2O)(calculated on the dried basis)

Density 

1.3619 (rough estimate)

refractive index 

117.5 ° (C=1, H2O)

storage temp. 

2-8°C

solubility 

H2O: 10-50 mg/mL As a stock solution. Stock solutions should be stored at 2-8°C. Stable at 37°C for 5 days.

form 

powder

color 

white to off-white

PH Range

6.5 - 8.5 (1% solution)

Water Solubility 

Soluble in water at 10mg/ml

Merck 

14,5281

InChIKey

OOYGSFOGFJDDHP-KMCOLRRFSA-N


Xi'an Eastling biotech Co., Ltd. is dedicated to the research and development, production, and sales of natural plant extracts; With nearly 15 years of experience in identifying, researching, developing, and producing active ingredients for medicinal plants, we focus on providing innovative products and services to customers in industries such as pharmaceuticals, health food, and cosmetics.

 

Eastling Biotechnology has established a global direct harvesting system for plant raw materials, ensuring the high quality and authenticity of raw materials, while also protecting the continuity and diversity of plants; Having strong research and development capabilities, we can develop more effective and specialized plant active ingredients for the pharmaceutical, health food, and cosmetics industries; We have established an advanced quality control system, and the quality control of our products depends on advanced testing instruments and high-level technical experts. The effective combination of the two forms Eastling's ability to quickly and rigorously control product quality.

 

We have a production system that complies with Chinese GMP and American cGMP certifications, as well as advanced and optimized large-scale industrial production technology. In addition to producing specific products for Eastling Biotechnology, we also provide customized services to meet the characteristics and needs of different customers to produce customized products.

We believe that natural active ingredients are the foundation of our service to customers. Scientific and effective production technology is the foundation for us to provide customers with specialized products. We have the ability to serve customers in the pharmaceutical, health food, and cosmetics industries, provide new product solutions, and add new value to their products.